Accuri C6 Flow Cytometer System
A more recent version of this article appeared on August 1, 2006

Published online before print June 12, 2006
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow Supplemental Data: jlb.0206112, Brown et al
Right arrow All Versions of this Article:
jlb.0206112v1
80/2/433    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brown, A. L.
Right arrow Articles by D’Andrea, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown, A. L.
Right arrow Articles by D’Andrea, R. J.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0206112


Received for publication February 23, 2006.
Revised March 20, 2006.
Accepted for publication March 23, 2006.


Article

Genetic regulators of myelopoiesis and leukemic signaling identified by gene profiling and linear modeling

Anna L. Brown *{dagger}{ddagger}, Christopher R. Wilkinson *{dagger}{ddagger}{sect}, Scott R. Waterman , Chung H. Kok *{dagger}{ddagger}, Diana G. Salerno *{dagger}{ddagger}, Sonya M. Diakiw *{dagger}{ddagger}, Brenton Reynolds *{dagger}{ddagger}, Hamish S. Scott ||, Anna Tsykin {sect}, Gary F. Glonek {sect}, Gregory J. Goodall ¶**, Patty J. Solomon {sect}, Thomas J. Gonda {dagger}{dagger}, and Richard J. D’Andrea *{dagger}{ddagger}@

*Haematology and Oncology Program, Child Health Research Institute, North Adelaide, South Australia; {dagger}The Queen Elizabeth Hospital, Woodville, South Australia; Departments of {ddagger}Paediatrics and **Medicine and {sect}School of Mathematical Sciences, University of Adelaide, South Australia; The Division of Human Immunology and Hanson Institute, Institute of Medical and Veterinary Sciences, Adelaide, South Australia; ||The Genetics and Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia; and {dagger}{dagger}Cancer Biology Program, Centre for Immunology and Cancer Research, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia

@ To whom correspondence should be addressed. E-mail: Richard.dandrea{at}adelaide.edu.au.


arrow
Abstract

Mechanisms controlling the balance between proliferation and self-renewal versus growth suppression and differentiation during normal and leukemic myelopoiesis are not understood. We have used the bi-potent FDB1 myeloid cell line model, which is responsive to myelopoietic cytokines and activated mutants of the granulocyte macrophage-colony stimulating factor (GM-CSF) receptor, having differential signaling and leukemogenic activity. This model is suited to large-scale gene-profiling, and we have used a factorial time-course design to generate a substantial and powerful data set. Linear modeling was used to identify gene-expression changes associated with continued proliferation, differentiation, or leukemic receptor signaling. We focused on the changing transcription factor profile, defined a set of novel genes with potential to regulate myeloid growth and differentiation, and demonstrated that the FDB1 cell line model is responsive to forced expression of oncogenes identified in this study. We also identified gene-expression changes associated specifically with the leukemic GM-CSF receptor mutant, V449E. Signaling from this receptor mutant down-regulates CCAAT/enhancer-binding protein {alpha} (C/EBP{alpha}) target genes and generates changes characteristic of a specific acute myeloid leukemia signature, defined previously by gene-expression profiling and associated with C/EBP{alpha} mutations.

Key Words: myeloid • transcription factor • myeloid leukemia • microarray • gene expression




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
D. R. Pattabiraman, J. Sun, D. H. Dowhan, S. Ishii, and T. J. Gonda
Mutations in Multiple Domains of c-Myb Disrupt Interaction with CBP/p300 and Abrogate Myeloid Transforming Ability
Mol. Cancer Res., September 1, 2009; 7(9): 1477 - 1486.
[Abstract] [Full Text] [PDF]